EP3565546

THROMBOLYTIC AGENT AND BEVACIZUMAB FOR TREATMENT OF CEREBRAL ISCHEMIA

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    4.1.2018
  • EP published:
    9.8.2023
  • EP application number:
    18736165.4
  • Max expiry date:
    3.1.2038
  • Title in English:
    THROMBOLYTIC AGENT AND BEVACIZUMAB FOR TREATMENT OF CEREBRAL ISCHEMIA
  • Language of the patent:
    English

Timeline

Today
4.1.2018EP application
9.8.2023EP Publication

Owner

  • Name:
    Shimojani LLC
  • Address:
    409 Illinois Street, San Francisco, CA 94158, US

Inventor

  • Name:
    KAUVAR, Lawrence M.
  • Address:
    San Francisco, CA 94109, US
  • Name:
    JANIGRO, Damir
  • Address:
    Cleveland Heights, OH 44106, US

Priority

  • Number:
    201762442826 P
  • Date:
    5.1.2017
  • Country:
    US
  • Number:
    201762470086 P
  • Date:
    10.3.2017
  • Country:
    US

Classification

  • Categories:
    A61K 31/404, A61K 31/444, A61K 31/44, A61K 31/4439, A61K 31/47, A61K 31/506, A61K 31/53, A61K 45/06, A61K 39/00, A61P 9/10, C07K 16/22, C07K 16/28, G01N 33/49, A61K 38/49, A61K 31/4709

Upload documents